Study of the Safety of BEMA™ Fentanyl Use for Breakthrough Pain in Cancer Subjects on Chronic Opioid Therapy

NCT00293020 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

244

Enrollment

INDUSTRY

Sponsor class

Conditions

Pain
Cancer

Interventions

DRUG: BEMA Fentanyl

Sponsor

BioDelivery Sciences International